Torsemide/Spironolactone ER Fixed-Dose Combination

Torsemide and Spironolactone extended-release fixed-dose combination · Sarfez Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Torsemide/Spironolactone ER Fixed-Dose Combination, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects [Phase 3]

See pricing